BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 2, 2026
Home » Authors » Sergio Held

Articles by Sergio Held

Conspirators have still not been named: Brazil investigates med-tech cartel, companies could face massive fines

Dec. 17, 2015
By Sergio Held

Sanofi Pasteur dengue vaccine gets world-first approval in Mexico

Dec. 11, 2015
By Sergio Held
BOGOTA, Colombia – Mexico became the first country in the world this week to approve a Sanofi Pasteur vaccine for dengue, a product that has been in development for two decades.
Read More

Program to promote awareness of the disease: Boston Scientific expands fight against Chagas in LatAm; ICDs behind the strategy

Dec. 9, 2015
By Sergio Held

How High is the Maximum?: Colombia's med-tech price caps under scrutiny

Dec. 7, 2015
By Sergio Held

Third pathway, price caps lead Sanofi's concerns in Colombia

Dec. 7, 2015
By Sergio Held
BOGOTA, Colombia – With a dengue vaccine on the way and double-digit growth this year, multinational pharmaceutical firm Sanofi SA has high expectations for its future in Colombia.
Read More

Colombia defining technological device evaluation guidelines

Nov. 16, 2015
By Sergio Held

Pharma companies fined in Colombia for breaching price caps

Nov. 9, 2015
By Sergio Held
BOGOTA, Colombia – Regulators in Colombia have fined six pharmaceutical companies for breaching price caps set by the National Board of Prices of Drugs. Among the companies targeted are Novartis AG and Sanofi-Aventis.
Read More

Soap opera continues for company: Brazilian silicone implant nightmare having major impact on Sientra shares

Nov. 4, 2015
By Sergio Held

BIO Latin America 2015: Brazil's ability to grow biotech sector hindered by Latin American government

Oct. 22, 2015
By Sergio Held

Brazil’s ability to grow biotech sector is hindered by government

Oct. 22, 2015
By Sergio Held
RIO DE JANEIRO – Difficulties carrying out clinical trials in Brazil may be hurting the development of the biotech sector in Latin American countries, particularly Brazil.
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 1, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Liver with hepatitis viruses, blood cells

    Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

    BioWorld
    GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing